A 260-person study reports hormone therapy significantly reduced severe menopause mood swings. Learn how these findings impact women veterans and VA healthcare.
If you are in immediate danger, call 911. For immediate mental health support, dial 988 and press 1 for the Veterans Crisis Line, or text 838255.
Between January 2023 and April 2025, researchers tracked a clinical cohort of 260 women treated at NYU Langone Health’s Center for Midlife Health and Menopause. A new study published in the journal Menopause detailed the outcomes of these patients. The research team found that federally approved hormone therapy was associated with a significant reduction in severe mood symptoms. Dr. Samantha Fairweather, an obstetrics and gynecology resident at NYU Grossman School of Medicine, served as the lead researcher.
The study utilized a retrospective, observational design to evaluate patient outcomes in a real clinical setting. Before beginning treatment, participants completed a detailed menopause symptom checklist to establish a baseline. They completed the same assessment at a follow-up visit, which was typically scheduled about three months later. The core finding focused on the specific change in psychological well-being over that short timeframe.
HealthDay reported that as many as 68% of menopausal women may experience depressed mood, irritability, anxiety, or mental exhaustion. This broad statistic serves as background context rather than a direct result of the new study. However, the report notes that estrogen is linked with brain blood flow and neuron function. This offers a possible biological rationale for mood-related effects, but the study does not establish that mechanism directly.
According to a U.S. Medicine report, nearly half of women veterans receiving VA health care are in the age range when menopause is most likely to occur. This demographic reality makes midlife health a pressing priority for military healthcare systems. Recent reporting on a planned Ohio State study suggests that women veterans may experience menopause earlier than civilians. Furthermore, their symptom burdens are often affected by trauma and depression.
Military service-related anxiety and chronic pain can also complicate these ongoing health challenges. VA research and care materials recognize menopause-related insomnia, hot flashes, difficulty concentrating, and mood changes as symptoms that affect women veterans. When layered with prior military trauma, the physical and psychological toll can become difficult to manage without clinical intervention. Dr. Monica Christmas, associate medical director of The Menopause Society, noted that the menopause transition can be highly distressing.
She explained that recognizing and addressing mood symptoms can significantly affect relationships and daily work performance. I remember waking up after a poor night of sleep and realizing that my training recovery was taking much longer than it used to. I realized that readiness is more than just pushing through the fatigue. It requires a dedicated approach to sleep and hormonal health, which completely shifted how I view long-term capability.
The data revealed a marked shift in patient-reported severity following the clinical intervention. The percentage of participants classified as having severe mood symptoms fell from approximately 62% before treatment to just under 25% at follow-up. A more precise secondary report detailed this change as dropping from 62.3% to 24.6%. The researchers noted that improvement was greatest among women who experienced the most severe mood symptoms at baseline.
The reported response did not differ according to participants’ age or their specific stage of menopause. Crucially, the researchers reported improvements in psychological and sleep disruption measures across diverse patient groups. This included positive outcomes for women with established psychiatric histories and those actively taking antidepressants. Response rates remained consistent regardless of prior psychiatric background or current antidepressant use.
In addition to mood benefits, sleep symptoms also showed measurable improvement during the observation period. One report described a mean sleep score difference of negative 1.0 for the cohort. This finding was supported by a 95 percent confidence interval ranging from negative 1.13 to negative 0.86, and a highly significant P value below 0.001. Some outcomes were self-reported, which is common in symptom research.
However, this introduces the possibility that responses were influenced by recall, patient expectations, or changes in how participants interpreted their symptoms. The central finding is clinically relevant but must be described strictly as an association rather than proof of causation. The study was retrospective and lacked a placebo control group. Symptoms could have improved due to time, clinical support, patient expectations, or concurrent treatments.
Furthermore, there was no untreated comparison group, so the exact magnitude of the treatment-specific effect cannot be isolated. Additionally, the small sample size of 260 patients and their commercial insurance profile may limit generalizability. The cohort's predominant use of one type of estradiol could also restrict how broadly the results apply to VA patients or active-duty servicewomen. The available reporting does not provide extensive detail about the specific hormone formulations, doses, or treatment durations.
It also lacks data on the racial and ethnic composition of the cohort, making it unclear if the results apply equally to all patient groups. The study supports discussion of hormone therapy as a possible option for menopause-related mood and sleep symptoms. However, it does not establish mood improvement as a standalone indication for every single patient. Care teams must still weigh the distinct biological needs of each individual.
For military and veteran audiences, the most defensible takeaway is that menopause-related mood and sleep problems deserve serious clinical attention. Servicewomen experiencing new mood swings, anxiety, irritability, hot flashes, or concentration problems should discuss the full symptom pattern with a clinician. They should not assume these challenges are purely psychological or simply an unavoidable part of aging. Hormone therapy decisions require a highly individualized assessment of the formulation, route, duration, and overall health profile.
A practical clinical discussion should include the timing of symptoms, current sleep quality, and the patient's menstrual stage. Clinicians also need to know about any current psychiatric medications, prior mental health history, and cardiovascular or cancer history. Patients with a history of stroke, thromboembolism, unexplained bleeding, or significant liver disease require particular caution or avoidance. Guidance summarized in the available sources outlines a generally more favorable benefit-risk balance for healthy symptomatic women younger than 60.
The same favorable safety profile applies to those within 10 years of menopause onset. Conversely, the medical risks become less favorable with older age or a longer interval since menopause began. Hormone therapy should never be started or stopped solely based on a news report. The observational nature of this study makes the findings encouraging but not definitive.
Veterans navigating healthy aging have multiple access points for care through the VA. They can begin by scheduling a visit with their primary care team or by asking for the local Women Veterans Program Manager. Additionally, the VA’s Women Veterans Call Center can be reached directly by call or text at 1-855-VA-WOMEN. A Government Accountability Office investigation found that many women veterans were completely unaware that VA menopause services existed.
VA menopause resources identify multiple medical treatment options, including hormone patches, hormone pills, and vaginal estrogen. They also emphasize nonmedical approaches like structured mental health support, targeted exercise, and nutrition. For patients who prefer a nonhormonal approach, a separate VA-supported pilot study involving 43 perimenopausal or postmenopausal women found promising results. That specific study demonstrated that a menopause-adapted cognitive-behavioral intervention improved insomnia and reduced hot flash interference compared with standard menopause education.
That specific study evaluated behavioral therapy rather than hormone therapy. It should not be presented as evidence that the two treatments are equivalent. The VA pilot had limitations like small sample sizes and uneven groups. Researchers also noted self-reported outcomes, short follow-up periods, and participant attrition by three months.
The recent NYU study does not establish that hormone therapy is an appropriate primary treatment for distinct clinical conditions. The findings do not suggest that hormone therapy replaces necessary psychiatric treatment or antidepressants. Anyone experiencing suicidal thoughts, severe depression, mania, or psychosis needs prompt mental health evaluation rather than relying on menopause care alone. Mood symptoms may reflect broader issues like clinical depression, trauma-related illness, or underlying sleep disorders that require specialized care.
As emerging research continues to investigate the complex ways military trauma and chronic pain intersect with midlife health, how will future clinical trials adapt their protocols to better serve the unique medical realities of aging women veterans?
Follow BattleVet for practical guidance on military and veteran health, strength, recovery, testosterone, sleep and healthy aging. Stay connected for new articles, research backed insights and clear information to help you stay capable for the years ahead.
A preclinical study reveals how rare Sst-Chodl neurons actively drive sleep. Learn what this neuroscience means for veteran health and natural recovery.
A 2026 study reveals that rural veterans discharged from VA hospitals face lower readmission rates but a 20 percent higher risk of short term mortality.
A 2026 OIG review identifies severe staffing shortages across 139 VA health facilities, impacting mental health and nursing roles. Plan your care proactively.
Build better habits around strength, recovery, sleep, hormones and healthy aging with practical guidance for active military personnel and veterans.
Explore BattleVet